Trial Profile
A Phase 2 Study to Evaluate the Safety Efficacy of Two Dose/Volume Levels of a Single Intrathecal Preoperative Administration of AYX1 Injection in Patients Undergoing Unilateral Total Knee Arthroplasty
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2016
Price :
$35
*
At a glance
- Drugs Brivoligide (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Adynxx
- 30 Sep 2016 Primary endpoint (Pain with walking during 15 meter walk test for AYX1 1100mg/10 mL dose) has not been met, according to results presented at the 16th World Congress on Pain.
- 30 Sep 2016 Primary endpoint (Pain with walking during 15 meter walk test for AYX1 660mg/6 mL dose) has been met, according to results presented at the 16th World Congress on Pain.
- 30 Sep 2016 Results of this study, presented at the 16th World Congress on Pain.